Understanding genetic architecture and how changes in the human genome may link to disease phenotypes is fundamental in order to gain mechanistic insights into the causes of complex malignancies such as cancer or neurodegenerative diseases.
A major focus of our research is developing new quantitative methods to identify variants linked to disease, as well as to build predictive models of disease emergence or response to therapy. To tackle these complex questions, we apply multiple statistical and computational strategies with focus on:
- Leveraging unique characteristics of different populations in order to identify genetic and environmental risk factors of complex diseases such as cancer, cardiovascular disease or depressive disorders (Kuchenbaecker lab)
- Developing improved statistical methods for the genetic analysis of rare and common diseases, such as schizophrenia (Curtis lab)
- Employing machine learning and data integration approaches to shed light into regulatory mechanisms and progression of cancer (Secrier lab).
Research on Human Disease and Cancer is funded by:
- Academy of Medical Sciences
- ERC
- UKRI
- Wellcome Trust, and others
People:
Dave Curtis
Karoline Kuchenbaecker
Alvina Lai
Maria Secrier
Nik Maniatis
Recent Papers
Lai lab investigates the role of the AMPK pathway in predicting clinical outcome in cancer.
Learn More
Maria Secrier: Tracing genomic histories and environmental influences in cancer development
Alvina Lai: DATA-CAN: The Health Data Research Hub for Cancer - impact of Covid-19 on cancer care
Cancer Domain Early Careers Network
News
Events
Contact Us
UCL Genetics Institute
Darwin Building
University College London
Gower Street, London WC1E 6BT
UGI Home Page
Link
Other UGI Research Themes
Link
- Microbial Genomics
- Human Population Genetics
- Ancient DNA
- Plants and Crops
- Computational Methods and Resources
UGI People
Link
Information about our people and our individual research groups

